Pamidronateisabisphosphonatethatexhibitsanti-resorptiveandanti-osteoporoticactivities.Pamidronateisclinicallyusedtopreventinjury-orchemotherapy-inducedboneloss.Clinically,pamidronateincreasesmusclefiber,bonestrength,andbonedensity.Thiscompoundalsopreventscancermetastasistobonetissue.
| CasNo. | 109552-15-0 |
|---|---|
| Purity | ≥98% |
| Formula | C3H9NNa2O7P2•5H2O |
| FormulaWt. | 369.11 |
| ChemicalName | (3-Amino-1-hydroxypropylidene)bisphosphonicaciddisodiumsaltpentahydrate |
| IUPACName | disodium;[3-amino-1-hyd |
| Synonym | Pamidronicaciddisodiumsaltpentahydrate |
| MeltingPoint | 300°C |
| Solubility | Solubleinwater. |
| Appearance | WhiteCrystallinePowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| MSDS | P0049MSDSPDF |
|---|---|
| InfoSheet | P0049InfoSheetPDF |
BørsheimE,HerndonDN,HawkinsHK,etal.Pamidronateattenuatesmusclelossafterpediatricburninjury.JBoneMinerRes.2014Jun;29(6):1369-72.PMID:24347438.
LaRocheM,LivideanuC,PaulC,etal.Interferonalphaandpamidronateinosteoporosiswithfracturesecondarytomastocytosis.AmJMed.2011Aug;124(8):776-8.PMID:21787907.
KokufuI,KohnoN,YamamotoM,etal.Adjuvantpamidronatetherapypreventsthedevelopmentofbonemetastasesinbreastcancerpatientswithfourormorepositivenodes.OncolLett.2010Mar;1(2):247-252.PMID:22966289.
MawardiH,GiroG,KajiyaM,etal.Aroleoforalbacteriainbisphosphonate-inducedosteonecrosisofthejaw.JDentRes.2011Nov;90(11):1339-1345.PMID:21921248.
